FY, 2019 | |
---|---|
Revenue | kr16.69 m |
Immunicum revenue breakdown by business segment: 100.0% from PHARMACEUTICAL BIOLOG/VACCINES
FY, 2021 | FY, 2019 | |
---|---|---|
PHARMACEUTICAL BIOLOG/VACCINES | kr31 | kr16.69 k |
FY, 2019 | |
---|---|
SWEDEN | kr16.69 k |
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.